cervical cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The patient is fully voluntary and has autonomy, having signed the informed consent form for the study 30 days prior to enrollment; (2) The patient is aged >= 18 years and <= 70 years; (3) The patient has pathologically confirmed cervical cancer, which can be squamous cell carcinoma, adenocarcinoma, adenosquamous cell carcinoma, etc., and requires a concurrent chemoradiotherapy treatment plan; (4) The subject must complete the entire radiation therapy process at our hospital; (5) The case data is complete, including height and weight prior to localization; (6) The Eastern Cooperative Oncology Group (ECOG) score is 0-2 points.
Exclusion criteria
Exclusion criteria: (1) Any patient with abnormal bone marrow hyperplasia or other hematopoietic dysfunction; (2) Patients with clinical symptoms or requiring drainage of pleural fluid, ascites, or pericardial effusion (patients who do not require drainage or show no significant increase in fluid accumulation within 3 days of stopping drainage are eligible for inclusion); (3) Other severe, acute, or chronic medical conditions or laboratory abnormalities that, in the researcher's opinion, may increase the risks associated with study participation or interfere with the interpretation of research results. (4) Patients with comorbid malignant tumors; (5) Those with poor compliance and unable to participate in the scheduled protocol on time; (6) Other situations deemed unsuitable for inclusion by researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| radiation enteritis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Immune factors, inflammatory factors;Biochemical indicators; | — |
Countries
China
Contacts
Henan Cancer Hospital